[1] Martin SD, McGee SL. Metabolic reprogramming in type 2 diabetes and the development of breast cancer[J]. J Endocrinol, 2018, 237: R35-R46. [2] Mu L, Zhu N, Zhang J, et al. Type 2 diabetes, insulin treatment and prognosis of breast cancer[J]. Diabetes Metab Res Rev, 2017, 33: e2823.doi: 10.1002/dmrr.2823. [3] Kachamakova-Trojanowska N, Podkalicka P, Bogacz T, et al. HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo[J]. Biochem Pharmacol, 2020, 20:113922.doi: 10.1016/j.bcp.2020.113922. [4] Zhong W, Chen S, Qin Y, et al. Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway[J]. Oncotarget, 2017, 8:104855-104866. [5] Sohn EJ, Jung DB, Lee HJ, et al. CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells[J]. Cancer Lett, 2018, 412:88-98. [6] 邵为, 林涛, 仲海燕, 等. 缺氧微环境对乳腺癌骨转移机制的研究进展[J]. 医学研究杂志, 2019,48:16-19+54. [7] Dewangan J, Kaushik S, Rath SK, et al. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis[J]. Life Sci, 2017, 193:9-19. [8] Niu F, Li Y, Lai FF, et al. LB-1 exerts antitumor activity in pancreatic cancer by inhibiting HIF-1 and Stat3 signaling[J]. J Cell Physiol, 2015, 230:2212-2223. [9] 李君强, 蒋茂芬, 陈国荣. 分析在胃癌组织中HIF-1α、VEGF的表达情况及意义[J]. 中国生化药物杂志, 2017, 37:22-25. [10] Hoffmann C, Mao XQ, Joshua BC, et al. Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2[J]. Sci Rep, 2018, 8:10191. doi: 10.1038/s41598-018-28637-x. [11] Lidfeldt J, Bendahl PO, Forsare C, et al. Protease activated receptors 1 and 2 correlate differently with breast cancer aggressiveness depending on tumor ER status[J]. PLoS One, 2015, 10:e0134932. doi: 10.1371/journal.pone.0134932. [12] Zigler M, Kamiya T, Brantley EC, et al. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis[J]. Cancer Res, 2011, 71: 6561-6566. [13] Li S, Wang L, Meng Y, et al. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients[J]. Oncotarget, 2017, 8:41282-41293. [14] Guo X, Lee S, Cao P, et al. The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivo[J]. Onco Targets Ther, 2019,12:825-834. [15] Lu Y, Wang L, Ding W, et al. Ammonia mediates mitochondrial uncoupling and promotes glycolysis via HIF-1 activation in human breast cancer MDA-MB-231 cells[J]. Biochem Biophys Res Commun, 2019,519:153-159. |